SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

CStone Reports CS2009 Data From More Than 300 Patients at ESMO

CStone said data from more than 300 patients supported CS2009’s mechanism, safety and antitumor activity across multiple solid tumors.

2616

Related stories